{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:37:21Z","timestamp":1791272241548,"version":"4.1.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:00:00Z","timestamp":1459900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151832","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T15:33:05Z","timestamp":1459956785000},"page":"e0151832","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":77,"title":["Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model"],"prefix":"10.1371","volume":"11","author":[{"given":"Jennifer A.","family":"MacDiarmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Langova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke R.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatsala N.","family":"Brahmbhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Smolarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy B.","family":"Mugridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Sedliarou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Stillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Hann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Gallia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Brahmbhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,6]]},"reference":[{"issue":"9311","key":"ref1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","article-title":"Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials","volume":"359","author":"LA Stewart","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"R Stupp","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"18","key":"ref3","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.biomaterials.2009.02.030","article-title":"Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme","volume":"30","author":"BY Ong","year":"2009","journal-title":"Biomaterials"},{"issue":"40","key":"ref4","doi-asserted-by":"crossref","first-page":"405101","DOI":"10.1088\/0957-4484\/24\/40\/405101","article-title":"Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes","volume":"24","author":"Y Yang","year":"2013","journal-title":"Nanotechnology"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/17425247.2012.682726","article-title":"Recent advances in brain tumor-targeted nano-drug delivery systems","volume":"9","author":"Y Liu","year":"2012","journal-title":"Expert opinion on drug delivery"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment","volume":"95","author":"SK Hobbs","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref7","first-page":"61","article-title":"Biology of brain metastases and novel targeted therapies: time to translate the research","volume":"1835","author":"E Fokas","year":"2013","journal-title":"Biochimica et biophysica acta"},{"issue":"1\u20132","key":"ref8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"WM Pardridge","year":"2007","journal-title":"Drug discovery today"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399411001888","article-title":"Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain","volume":"13","author":"S Agarwal","year":"2011","journal-title":"Expert reviews in molecular medicine"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/10611860903548354","article-title":"Biopharmaceutical drug targeting to the brain","volume":"18","author":"WM Pardridge","year":"2010","journal-title":"Journal of drug targeting"},{"issue":"23\u201324","key":"ref11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.drudis.2008.09.005","article-title":"The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?","volume":"13","author":"L Juillerat-Jeanneret","year":"2008","journal-title":"Drug discovery today"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"J Kreuter","year":"2001","journal-title":"Advanced drug delivery reviews"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood-brain barrier and cancer: transporters, treatment, and Trojan horses","volume":"13","author":"JF Deeken","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1479-5876-6-80","article-title":"Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells","volume":"6","author":"H Sarin","year":"2008","journal-title":"Journal of translational medicine"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425240903167942","article-title":"New strategies to deliver anticancer drugs to brain tumors","volume":"6","author":"V Laquintana","year":"2009","journal-title":"Expert opinion on drug delivery"},{"issue":"1","key":"ref16","first-page":"158","article-title":"Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies","volume":"1836","author":"L Chen","year":"2013","journal-title":"Biochimica et biophysica acta"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/foc.2000.8.4.2","article-title":"Astrocytoma models","volume":"8","author":"H Ding","year":"2000","journal-title":"Neurosurgical Focus"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"e1000161","DOI":"10.1371\/journal.pmed.1000161","article-title":"The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway","volume":"6","author":"I Gordon","year":"2009","journal-title":"PLoS medicine"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of new cancer treatments from pet dogs to humans","volume":"8","author":"M Paoloni","year":"2008","journal-title":"Nature reviews Cancer"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-007-9400-9","article-title":"Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression","volume":"85","author":"M Candolfi","year":"2007","journal-title":"Journal of neuro-oncology"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1354\/vp.40-6-659","article-title":"Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs","volume":"40","author":"D Lipsitz","year":"2003","journal-title":"Veterinary pathology"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1158\/0008-5472.CAN-06-3792","article-title":"Faithful companions: a proposal for neurooncology trials in pet dogs","volume":"67","author":"J Kimmelman","year":"2007","journal-title":"Cancer research"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1939-1676.1988.tb02796.x","article-title":"Clinical signs of tumors affecting the rostral cerebrum in 43 dogs","volume":"2","author":"ES Foster","year":"1988","journal-title":"Journal of veterinary internal medicine \/ American College of Veterinary Internal Medicine"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1939-1676.1991.tb00952.x","article-title":"Analysis of survival in a retrospective study of 86 dogs with brain tumors","volume":"5","author":"GL Heidner","year":"1991","journal-title":"Journal of veterinary internal medicine \/ American College of Veterinary Internal Medicine"},{"issue":"19","key":"ref25","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.vaccine.2010.02.082","article-title":"Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy","volume":"28","author":"GE Pluhar","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccr.2007.03.012","article-title":"Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics","volume":"11","author":"JA MacDiarmid","year":"2007","journal-title":"Cancer cell"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ctrv.2004.04.001","article-title":"Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?","volume":"30","author":"EM Kemper","year":"2004","journal-title":"Cancer treatment reviews"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ijc.2910580619","article-title":"Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells","volume":"58","author":"T Abe","year":"1994","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1026234130830","article-title":"BR96-DOX immunoconjugate targeting of chemotherapy in brain tumor models","volume":"65","author":"LL Muldoon","year":"2003","journal-title":"Journal of neuro-oncology"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nbt.1547","article-title":"Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug","volume":"27","author":"JA MacDiarmid","year":"2009","journal-title":"Nature biotechnology"},{"issue":"16","key":"ref31","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jnci\/93.16.1246","article-title":"PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme","volume":"93","author":"JS Smith","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-009-0072-5","article-title":"Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping","volume":"98","author":"RJ Higgins","year":"2010","journal-title":"Journal of neuro-oncology"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1874467211003010037","article-title":"EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance","volume":"3","author":"HW Lo","year":"2010","journal-title":"Current molecular pharmacology"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156800912799277557","article-title":"Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance","volume":"12","author":"TE Taylor","year":"2012","journal-title":"Current cancer drug targets"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"O Tacar","year":"2013","journal-title":"The Journal of pharmacy and pharmacology"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/01652176.1998.9694829","article-title":"Comparison of attenuation and liver-kidney contrast of liver ultrasonographs with histology and biochemistry in dogs with experimentally induced steroid hepatopathy","volume":"20","author":"M Syakalima","year":"1998","journal-title":"The Veterinary quarterly"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1939-1676.2000.tb01167.x","article-title":"Thyroid function and serum hepatic enzyme activity in dogs after phenobarbital administration","volume":"14","author":"TL Gieger","year":"2000","journal-title":"Journal of veterinary internal medicine \/ American College of Veterinary Internal Medicine"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"R Sabat","year":"2010","journal-title":"Cytokine & growth factor reviews"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0528.2002.017404.x","article-title":"The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses","volume":"174","author":"S Seki","year":"2000","journal-title":"Immunological reviews"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"868345","DOI":"10.1155\/2011\/868345","article-title":"Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells","volume":"2011","author":"S Seki","year":"2011","journal-title":"Clinical & developmental immunology"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/2.1.45","article-title":"The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery","volume":"2","author":"DR Groothuis","year":"2000","journal-title":"Neuro-oncology"},{"issue":"1\u20132","key":"ref42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"H Maeda","year":"2000","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/08982100600848769","article-title":"Pros and cons of the liposome platform in cancer drug targeting","volume":"16","author":"AA Gabizon","year":"2006","journal-title":"Journal of liposome research"},{"issue":"249","key":"ref44","doi-asserted-by":"crossref","first-page":"249ra111","DOI":"10.1126\/scitranslmed.3008982","article-title":"Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses","volume":"6","author":"NJ Roberts","year":"2014","journal-title":"Science translational medicine"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"e82331","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"PJ Gaillard","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls","volume":"4","author":"J Dietrich","year":"2011","journal-title":"Expert review of clinical pharmacology"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1172\/JCI118927","article-title":"Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor","volume":"98","author":"JD Heiss","year":"1996","journal-title":"The Journal of clinical investigation"},{"issue":"22","key":"ref48","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1200\/JCO.2004.07.960","article-title":"Phase II studies of modern drugs directed against new targets: if you are fazed, too, then resist RECIST","volume":"22","author":"MJ Ratain","year":"2004","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"23","key":"ref49","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"JD Wolchok","year":"2009","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jnen\/59.7.607","article-title":"Characterization of a canine glioma cell line as related to established experimental brain tumor models","volume":"59","author":"NG Rainov","year":"2000","journal-title":"Journal of neuropathology and experimental neurology"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.neo.7900020","article-title":"Allogeneic astrocytoma in immune competent dogs","volume":"1","author":"ME Berens","year":"1999","journal-title":"Neoplasia (New York, NY)"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5810.2004.0053b.x","article-title":"Veterinary Co-operative Oncology Group\u2014Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0","volume":"2","year":"2004","journal-title":"Veterinary and comparative oncology"},{"key":"ref54","first-page":"697","article-title":"Tumors of the nervous system: Tumors in domestic animals","author":"A Koestner","year":"2002"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T05:21:16Z","timestamp":1567747276000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151832"}},"subtitle":[],"editor":[{"given":"Joseph Alan","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,6]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151832","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,6]]}}}